| Literature DB >> 32303265 |
Eva J Brandl1,2, Nora Dietrich3,4, Nicoleta Mell3,4, Johanna G Winkler3,4, Stefan Gutwinski3,4, H Joachim Bretz3,4, Meryam Schouler-Ocak3,4.
Abstract
BACKGROUND: Sociodemographic factors, attitude towards treatment and acculturation may be important factors influencing the decision of immigrants to seek and maintain psychiatric treatment. A better understanding of these factors may significantly improve treatment adherence and outcome in these patients. Therefore, we investigated factors associated the attitude towards psychotherapy and medication in a sample of psychiatric outpatients with and without migration background.Entities:
Keywords: Attitude; Medication; Migrants; Psychotherapy
Mesh:
Year: 2020 PMID: 32303265 PMCID: PMC7164188 DOI: 10.1186/s12888-020-02585-1
Source DB: PubMed Journal: BMC Psychiatry ISSN: 1471-244X Impact factor: 3.630
Association of acculturation with attitude towards psychotherapy and medication
| Turkish background ( | Eastern European background ( | MENAP background ( | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Dependent Variable | |||||||||||||||
| .17* | .17 | 3.83 | .003* | .27 | .27 | 1.66 | .186 | .16 | .16 | 0.86 | .523 | ||||
| .20* | .03 | 1.91 | .154 | .50 | .23 | 4.61 | .022* | .19 | .03 | 0.42 | .662 | ||||
| Host national identification | |||||||||||||||
| Co-national identification | |||||||||||||||
| 100 | 26 | 29 | |||||||||||||
| .03 | .03 | 1.36 | .263 | .12 | .12 | 1.50 | .244 | .07 | .07 | 1.07 | .359 | ||||
| .06 | .03 | 1.17 | .315 | .23 | .11 | 1.54 | .237 | .07 | .00 | 0.01 | .994 | ||||
| Host national identification | |||||||||||||||
| Co-national identification | |||||||||||||||
| 90 | 26 | 30 | |||||||||||||
| .07 | .07 | 3.09 | .051 | .35* | .35 | 6.10 | .008* | .01 | .01 | 0.11 | .897 | ||||
| .12* | .05 | 2.56 | .083 | .39* | .04 | .76 | .480 | .04 | .03 | 0.42 | .663 | ||||
| Host national identification | |||||||||||||||
| Co- national Identification | |||||||||||||||
| 90 | 26 | 31 | |||||||||||||
| .19* | .19 | 3.12 | .008* | .47* | .47 | 2.71 | .047* | .02 | .02 | 0.07 | .998 | ||||
| .19* | .00 | 0.34 | .715 | .51 | .04 | 0.51 | .607 | .10 | .08 | 0.81 | .459 | ||||
| Host national identification | |||||||||||||||
| Co-national identification | |||||||||||||||
| 89 | 25 | 27 | |||||||||||||
| .09 | .09 | 2.37 | .058 | .28 | .28 | 2.24 | .096 | .19 | .19 | 1.57 | .212 | ||||
| .09 | .00 | 0.04 | .966 | .34 | .06 | 0.87 | .432 | .20 | .02 | 0.14 | .871 | ||||
| Host national identification | |||||||||||||||
| 2003Co-national identification | |||||||||||||||
| 98 | 28 | 31 | |||||||||||||
Main results of the hierarchical regression predicting the QUAPT scales judgment, competence, acceptance and general attitude as well as the DAI scale in the samples with Turkish, East European and MENAP background. The association of control variables with attitude towards psychotherapy and medication are included in Step 1. Acculturation scales are added to the other variates in the second step. For simplicity reasons, the control variables as well as the B- and β-values are not shown in this Table, details can be found in Supplementary Table S6. MENA = Middle East and North Africa Region, QUAPT = Questionnaire on Attitudes Toward Psychotherapeutic Treatment, DAI = Drug Attitude Inventory
* p < .05
Sociodemographic and symptom related characteristics of the total sample and the four subsamples
| Variable | Total sample | Sample without migration background | Sample with Turkish migration background | Sample with East European migration background | Sample with MENAP migration background | |
|---|---|---|---|---|---|---|
| Gender | ||||||
| female | 224 (58.8) | 100 (51.6) | 85 (76.6) | 21 (53.9) | 18 (48.6) | < .001* |
| male | 157 (41.2) | 94 (48.5) | 26 (23.4) | 18 (46.2) | 19 (51.4) | |
| Age | 43.9 (12.5) | 44.3 (13.4) | 45.3 (10.9) | 43.2 (13.2) | 38.2 (10.5) | .061 |
| School education | .009* | |||||
| high | 217 (57.0) | 126 (66.0) | 48 (43.2) | 25 (64.1) | 18 (48.6) | |
| low | 138 (36.2) | 60 (30.9) | 52 (46.8) | 12 (30.8) | 14 (37.8) | |
| not indicated | 26 (6.8) | 8 (4.1) | 11 (9.9) | 2 (5.1) | 5 (13.5) | |
| Country of birth | ||||||
| Germany | 223 (58.5) | 193 (99.5) | 19 (17.1) | 7 (17.9) | 4 (10.8) | |
| Other country | 158 (41.5) | 1 (USA) | 92 (Turkey) | 30 (82.1) (3 Bulgaria, 1 Czech Republic, 1 Hungary, 1 Kosovo, 1 Latvia, 10 Poland, 1 Rumania, 8 Russia, 4 Serbia, 1 Ukraine, 1 former Yugoslavia) | 33 (89.2) (4 Iraq, 2 Iran, 1 Israel, 6 Lebanon, 2 Morocco, 1 Pakistan, 16 Syria, 1 Tunisia) | |
| Religious affiliation | < .001* | |||||
| Yes | 230 (60.4) | 76 (39.2) | 97 (87.4) | 25 (64.1) | ||
| No | 122 (32.0) | 94 (48.5) | 11 (9.9) | 13 (33.3) | ||
| Not indicated | 29 (7.6) | 24 (12.4) | 3 (2.7) | 1 (2.6) | ||
| Medication intake | .597 | |||||
| Yes | 328 (86.1) | 160 (82.5) | 98 (88.3) | 35 (89.7) | 35 (34.6) | |
| No | 53(13.9) | 34 (17.5) | 13 (11.7) | 4 (10.3) | 2 (5.4) | |
| Number of medications | 1.5 (0.7) | 1.3 (1.0) | 1.5 (0.9) | 1.7 (1.1) | 1.5(0.7) | .014* |
| Type of medication | .003* | |||||
| Antidepressant | 269(70.6) | 109 (56.2) | 98 (88.3) | 31 (79.5) | 31 (83.8) | |
| Neuroleptic | 207 (54.3) | 111 (57.2) | 50 (45.0) | 22 (56.4) | 24 (64.9) | |
| Tranquillizer | 23 (6.9) | 13 (6.7) | 5 (4.5) | 4 (10.3) | 1 (2.7) | |
| Mood stabilizer | 37 (7.1) | 20 (10.3) | 8 (7.2) | 9 (23.1) | 0 (0.0) | |
| Antidementiva | 0(0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | |
| Pain Medication | 12 (4.3) | 2 (1.0) | 8 (7.2) | 2 (5.1) | 0 (0.0) | |
| Internal medication | 56 (14.7) | 35 (18.0) | 15 (13.5) | 3 (7.7) | 3 (8.1) | |
| Substitution/ addiction treatment medication | 1 (0.3) | 1 (0.5) | 0 (0.0) | 0 (0.0) | 0 (0.0) | |
| Other | 12 (3.1) | 5 (2.6) | 5 (4.5) | 0 (0.0) | 2 (5.4) | |
| Inpatient stays (psychiatry) | .005* | |||||
| never | 132 (34.6) | 49 (25.3) | 55 (49.5) | 7 (17.9) | 21 (56.7) | |
| seldom | 144 (37.8) | 76 (39.2) | 38 (34.2) | 20 (51.3) | 10 (27.0) | |
| often | 92 (24.1) | 63 (31.5) | 14 (12.6) | 10 (25.6) | 5 (13.5) | |
| not indicated | 13 (3.4) | 6 (3.1) | 4 (3.6) | 2 (5.1) | 1 (2.7) | |
| Symptom severity | ||||||
| SCL Somatization | 2.4 (1.2) | 2.0 (1.0) | 3.1 (1.3) | 2.4 (1.2) | 2.6 (1.0) | < .001* |
| SCL Depression | 2.8(1.1) | 2.6 (1.0) | 3.0 (1.1) | 3.2 (1.2) | 3.0 (1.0) | .184 |
| SCL Anxiety | 2.0 (1.0) | 1.7 (0.9) | 2.3 (1.1) | 1.9 (1.1) | 2.5 (1.2) | < .001* |
| Diagnosis (ICD-10) | ||||||
| F0 | 8 (2.1) | 7 (3.6) | 1 (0.9) | 0 (0.0) | 0 (0.0) | < .001* |
| F1 | 85 (30.2) | 65 (33.5) | 9 (8.1) | 5 (12.8) | 6 (16.2) | |
| F2 | 86 (30.6) | 51 (26.3) | 18 (16.2) | 9 (23.1) | 8 (21.6) | |
| F3 | 164 (43.0) | 79 (40.7) | 49 (44.1) | 15 (38.5) | 21 (56.8) | |
| F4 | 141 (37.0) | 50 (25.8) | 61 (55.0) | 15 (38.5) | 15 (40.5) | |
| F5 | 7 (1.8) | 3 (1.5) | 2 (1.8) | 2 (5.1) | 0 (0.0) | |
| F6 | 61 (16.0) | 46 (23.7) | 7 (6.3) | 8 (20.5) | 0 (0.0) | |
| F7 | 7 (1.8) | 7 (3.6) | 0 (0.0) | 0 (0.0) | 0 (0.0) | |
| F8 | 0(0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | |
| F9 | 2 (0.5 | 1 (0.5) | 1 (0.9) | 0 (0.0) | 0 (0.0) | |
Note. Low level of school education was defined as 0–9 years of school, a high level of school education as 10–13 years of school education (following Petrowski und Kollegen, 2014). Regarding the classification of inpatient stays, 1–2 inpatient stays were catigorized as seldom and more than 2 as often. MENA = Middle East and North Africa region, SCL = Symptom-Check-List, n = sample size, M = arithmetic mean, SD = standard deviation. Note. The number of diagnosis does not correspond with the sample size as some patients have multiple diagnosis. The diagnosis have been classified according to the International Classification of Diseases 10 (Graubner, 2014). F0 = Organic, including symptomatic, mental disorders, F1 = Mental and behavioural disorders due to use of psychoactive substances, F2 = Schizophrenia, schizotypal and delusional disorders, F3 = Mood/ affective disorders, F4 = Neurotic, stress-related and somatoform disorders, F5 = Behavioural syndromes associated with physiological disturbances and physical factors, F6 = Disorders of personality and behaviour in adult persons, F7 = Mental retardation, F8 = Disorders of psychological development, F9 = Behavioural and emotional disorders with onset usually occurring in childhood and adolescence
* p < .05